Perry Baromedical Acquires Hyperbaric Division of ETC

Perry Baromedical Corporation, (hyperbaric medical device manufacturing for over 58 years) today (February 18, 2020) announced they have acquired the hyperbaric division of Environmental Tectonics Corporation (ETC) of Southampton, PA which manufactures products under the “BARA-MED” brand.

This business unit acquisition advances Perry Baromedical into new international markets and expands the installed base in the US and abroad.  The timing provides a unique opportunity for ETC to divest themselves of a small business unit and allows Perry the opportunity for expansion in Asian Pacific markets.

According to Mary Pat Finn, President/COO of Perry Baromedical, “this was the perfect opportunity for Perry to acquire a specific hyperbaric design which meets the needs of new markets for Perry.  This acquisition will allow Perry to continue to market this brand with existing FDA and international certifications and use the design to expand into newer markets in Asia.

Perry will continue to sell equipment under the “BARA-MED” brand and continue to offer the best in class customer service of all the Baromed installed equipment in the US and globally.  As a company which is focused on quality hyperbaric designs, we want to approach each market with the best product offering to meet the needs of a given healthcare market”.

Perry will provide sales continuity of the Perry brand as well as offer the BARA-MED brand in various markets. With this acquisition, Perry maintains its commitment as the world hyperbaric industry leader.  Perry is the first and only hyperbaric medical device manufacturer to offer over 10 unique styles of hyperbaric designs without compromising quality and choice to meet the needs of patients worldwide.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”